Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Heidelberg
Clinical trial register · Australia

Clinical Trials in Heidelberg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3378 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:19 UTC
3378
Studies in scope
all four open statuses
1824
Recruiting now
open to new participants
781
Lead sponsors
across recruiting studies
Top sites
Melbourne 1113 Adelaide 582 Sydney 522 Westmead 422 Clayton 413
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca27 Janssen Research & Development, LLC16 Hoffmann-La Roche13 AbbVie12 Bristol-Myers Squibb9 Boehringer Ingelheim8 BeOne Medicines7 Olivia Newton-John Cancer Research Institute6 Eli Lilly and Company5 Merck Sharp & Dohme LLC5 Pfizer4 GlaxoSmithKline4 Amgen4 University of Melbourne4 Novartis Pharmaceuticals3 Regeneron Pharmaceuticals3 Longboard Pharmaceuticals3 Genmab3 ArriVent BioPharma, Inc.3 Acerta Pharma BV3 Celgene3 Daiichi Sankyo3 BioNTech SE3 Ascentage Pharma Group Inc.2 Revolution Medicines, Inc.2 Show all 128
Site location
Melbourne1113 Adelaide582 Sydney522 Westmead422 Clayton413 Nedlands383 Brisbane356 Camperdown350 Parkville320 South Brisbane314 Perth299 Heidelberg274 Darlinghurst246 Woolloongabba239 Randwick210 St Leonards199 Liverpool196 Murdoch190 Fitzroy177 Kogarah162 Box Hill156 Bedford Park154 Southport154 Wollongong149 Herston147 Show all 397
All 397 locations
Target enrolment
to

Trials with a site in Heidelberg

274 of 3378 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Olivia Newton-John Cancer Research Institute
Early Phase 1
12
Heidelberg
2027-03
Not yet open
Speed of Lung Inflation During Ventilation of Extremely Preterm Infants
NCT07101419Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant
Murdoch Childrens Research Institute
Not applicable
68
Heidelberg, Parkville, Saint Albans
2027-02
Not yet open
Olivia Newton-John Cancer Research Institute
Phase 2
25
Sydney, Woolloongabba, Clayton, Heidelberg, Nedlands
2027-01-01
Not yet open
Olivia Newton-John Cancer Research Institute
Phase 2
40
Douglas, Woolloongabba, Bedford Park, Heidelberg, Murdoch
2026-12
Not yet open
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma
NCT07739017Recurrent Glioblastoma, Newly Diagnosed MGMT Unmethylated Glioblastoma
Olivia Newton-John Cancer Research Institute
Phase 1
54
Sydney, Brisbane, Herston, Heidelberg, Melbourne
2026-12
Recruiting
AIMEDBIO
Phase 1
86
Heidelberg
2026-10-09
Recruiting
Takeda
Phase 3
324
Bedford Park, Garran, Coffs Harbour, Cudgen, Kogarah, Fitzroy, Heidelberg
2026-09-10
Recruiting
Bristol-Myers Squibb
Phase 2
160
Gosford, Westmead, Greenslopes, Heidelberg, Perth
2026-09-10
Not yet open
ResMed
Observational
90
Adelaide, Woodville South, Perth, Heidelberg
2026-09
Recruiting
Context Therapeutics Inc.
Phase 1
162
Wahroonga, Westmead, Gold Coast, Newcastle, Heidelberg, Perth
2026-09
Recruiting
VectivBio AG
Phase 3
124
Fitzroy, Heidelberg, Herston, Perth
2026-08
Recruiting
iVEAcare
Not applicable
30
Herston, South Brisbane, Clayton, Fitzroy, Heidelberg, Melbourne, Parkville
2026-07-29
Recruiting
Sovargen
Phase 1/2
12
Heidelberg, Melbourne
2026-07-14
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
NCT07476287Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer, Lung Neoplasms
DrugPF-08634404
Pfizer
Phase 2
40
Westmead, Elizabeth Vale, Heidelberg
2026-07-02
Recruiting
BeOne Medicines
Phase 1
118
Concord, Kogarah, Kurralta Park, Geelong, Heidelberg, Nedlands
2026-06-23
Recruiting
GlaxoSmithKline
Phase 1/2
49
Heidelberg
2026-06-19
Not yet open
Queensland Centre for Gynaecological Cancer
Phase 3
640
Newcastle, Darwin, Auchenflower, Brisbane, Buderim, Adelaide, Heidelberg, Parkville
2026-06-01
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Darlinghurst, Garran, Heidelberg, Macquarie University, Melbourne, Perth, Port Macquarie
2026-05-31
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 3
250
West Perth, Heidelberg, Kurralta Park
2026-05-25
Recruiting
Takeda
Phase 3
300
Coffs Harbour, Sydney, Waratah, Adelaide, Bedford Park, Clayton, Fitzroy, Heidelberg
2026-05-21
Recruiting
Ipsen
Phase 3
350
Saint Leonards, Westmead, Birtinya, South Brisbane, Adelaide, Heidelberg, Melbourne, Nedlands
2026-05-14
Recruiting
AstraZeneca
Phase 3
420
Adelaide, Fitzroy, Heidelberg, Nedlands, Perth, Rockingham
2026-05-05
Recruiting
Genentech, Inc.
Phase 1/2
260
Darlinghurst, Heidelberg
2026-04-29
Recruiting
Boehringer Ingelheim
Phase 2
405
Heidelberg, Murdoch
2026-04-20
Recruiting
Mediar Therapeutics
Phase 2
85
Southport, Woolloongabba, Heidelberg
2026-04-16
Recruiting
Bristol-Myers Squibb
Phase 1/2
474
North Ryde, St Leonards, Brisbane, Herston, Heidelberg, Malvern
2026-03-26
Recruiting
Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC
NCT07197580ccRCC, Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Renal Cell Cancer Metastatic
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
40
Sydney, Wollongong, Heidelberg, Melbourne N., Murdoch
2026-03-25
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Blacktown, Camperdown, Meadowbrook, Oaklands Park, Heidelberg, Melbourne
2026-03-23
Recruiting
Study in Advanced Solid Tumor Patients
NCT07300943Advanced Solid Tumor
Callio Therapeutics
Phase 1/2
306
Randwick, South Brisbane, Box Hill, Heidelberg, Melbourne, Nedlands
2026-03-19
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Blacktown, St Leonards, Oaklands Park, Heidelberg, Melbourne
2026-03-16
Recruiting
Avalyn Pharma Inc.
Phase 2
160
Camperdown, Kingswood, New Lambton Heights, Sydney, Westmead, Launceston, Heidelberg, Melbourne
2026-03-10
Recruiting
Hoffmann-La Roche
Phase 2
360
Camperdown, Kogarah, New Lambton Heights, Box Hill, Heidelberg
2026-03-10
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
DrugsCetuximab·Nab-paclitaxel·Gemcitabine
Revolution Medicines, Inc.
Phase 3
900
Kogarah, Randwick, Waratah, Herston, East Melbourne, Heidelberg
2026-03-09
Recruiting
AstraZeneca
Phase 3
2,130
Darlinghurst, Garran, Heidelberg, Murdoch, Randwick, Westmead, Woolloongabba
2026-02-03
Not yet open
St Vincent's Hospital Melbourne
Phase 2
115
Fitzroy, Heidelberg, Melbourne, Parkville
2026-02
Recruiting
Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
NCT07435038Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumors
Betta Pharmaceuticals Co., Ltd.
Phase 1/2
120
Blacktown, Randwick, Sydney, Bedford Park, Heidelberg, Nedlands
2026-01-29
Recruiting
BeOne Medicines
Phase 3
500
Blacktown, Concord, St Leonards, Woolloongabba, Clayton, Heidelberg, Malvern, Melbourne
2026-01-22
Recruiting
Vorasidenib Maintenance for IDH Mutant Astrocytoma
NCT06809322IDH-mutant Grade 2 or 3 Astrocytoma
DrugVorasidenib
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
468
Bedford Park, Camperdown, Heidelberg, Hobart, Liverpool, Melbourne, Nedlands, St Leonards
2026-01-16
Recruiting
Boehringer Ingelheim
Phase 3
400
Bedford Park, Subiaco, Heidelberg, Sydney, Woolloongabba
2026-01-16
Recruiting
Contineum Therapeutics
Phase 2
324
Camperdown, Westmead, Chermside, Greenslopes, Heidelberg, Melbourne, Midland, Spearwood
2026-01-08
Recruiting
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
NCT07224581GRIN-related Neurodevelopmental Disorder
DrugRadiprodil
GRIN Therapeutics, Inc.
Phase 3
100
South Brisbane, Heidelberg
2026-01-05
Recruiting
Regeneron Pharmaceuticals
Phase 3
915
Benowa, Brisbane, Southport, East Melbourne, Heidelberg, Melbourne, Perth, Adelaide
2026-01-02
Recruiting
European Myeloma Network B.V.
Phase 3
1,000
Adelaide, Box Hill, Canberra, Geelong, Heidelberg, Kingswood, Melbourne, Sunshine Coast
2025-12-23
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Heidelberg, Kurralta Park, Melbourne, Wahroonga, Woolloongabba
2025-12-19
Recruiting
ArriVent BioPharma, Inc.
Phase 3
480
Blacktown, Camperdown, St Leonards, Heidelberg
2025-12-17
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Box Hill, Brisbane, Campbelltown, Heidelberg, Macquarie University, Perth, Randwick, St Albans
2025-12-12
Recruiting
BeOne Medicines
Phase 1
186
Blacktown, Camperdown, Adelaide, Heidelberg, Melbourne
2025-12-11
Recruiting
Genmab
Phase 3
660
Heidelberg, Campbelltown, Camperdown, Gosford, Kingswood, Waratah, Joondalup
2025-11-28
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 2
78
Clayton, Heidelberg, Nedlands
2025-11-26
Recruiting
BioNTech SE
Phase 1/2
245
Clayton, Heidelberg
2025-11-18
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Camperdown, Kogarah, Macquarie Park, Bedford Park, Woodville, Box Hill, Heidelberg, Melbourne
2025-11-12
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Kogarah, New Lambton Heights, Westmead, Clayton, Heidelberg, Murdoch, Southport
2025-11-11
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Sydney, Waratah, South Brisbane, Adelaide, Clayton, Geelong, Heidelberg, Nedlands
2025-11-03
Recruiting
AstraZeneca
Phase 1
72
Heidelberg, Melbourne
2025-11-03
Recruiting
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
NCT07244705Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC), Immunotherapy
DrugsAvastin·Tislelizumab·Bevacizumab
Anbogen Therapeutics, Inc.
Phase 1/2
66
Liverpool, Macquarie Park, Randwick, Greenslopes, Woodville South, Clayton, Heidelberg, Nedlands
2025-11
Recruiting
Hoffmann-La Roche
Phase 3
600
Darlinghurst, Liverpool, Waratah, Birtinya, Hobart, Clayton, Heidelberg, Melbourne
2025-10-24
Recruiting
GlaxoSmithKline
Phase 3
1,200
Broadmeadow, Heidelberg
2025-10-24
Recruiting
Eli Lilly and Company
Phase 3
4,500
Adelaide, Box Hill, Brisbane, Broadmeadow, Geelong, Heidelberg, Ipswich, Murdoch
2025-10-15
Recruiting
Janssen Research & Development, LLC
Phase 2
60
Camperdown, Clayton, Heidelberg, Murdoch, Woolloongabba
2025-10-03
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Macquarie University, St Leonards, Heidelberg
2025-09-30
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Waratah, South Brisbane, Kurralta Park, Heidelberg, Melbourne, Murdoch
2025-09-26
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
424
Liverpool, Darlinghurst, Fitzroy, Heidelberg, Nedlands
2025-09-22
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
414
Camperdown, Sydney, Darlinghurst, Chermside, Heidelberg, Murdoch
2025-09-13
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Macquarie University, Brisbane, Ballarat Central, Heidelberg, Melbourne, Subiaco
2025-09-11
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Box Hill, Chermside, Elizabeth Vale, Frankston, Frenchs Forest, Heidelberg, Hobart, Kurralta Park
2025-09-08
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Heidelberg, Kurralta Park, Melbourne, Murdoch, Woolloongabba
2025-09-02
Recruiting
Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
NCT07055542Allergic Asthma, Thunderstorm Asthma, Seasonal Allergic Rhinitis, Grass Pollen Allergy
University of Melbourne
Not applicable
530
Albury, Box Hill, Clayton, Heidelberg, Melbourne, Parkville
2025-08-27
Recruiting
University of Minnesota
Observational
1,500
Camperdown, Sydney, Westmead, Brisbane, Clayton, Heidelberg, Melbourne, Parkville
2025-08-25
Recruiting
BioNTech SE
Phase 1/2
1,438
Blacktown, Darlinghurst, Wollstonecraft, Southport, Adelaide, Frankston, Heidelberg, Melbourne
2025-08-12
Recruiting
AstraZeneca
Phase 2
278
Heidelberg, Nedlands, Woodville
2025-08-07
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Camperdown, Kogarah, Box Hill, Heidelberg, Nedlands
2025-08-07
Recruiting
AbbVie
Phase 2/3
854
Liverpool, Woodville South, Heidelberg, Murdoch
2025-08-03
Recruiting
Celgene
Phase 3
400
Westmead, Adelaide, Hobart, Heidelberg, Malvern, Perth
2025-07-28
Recruiting
Celcuity Inc
Phase 3
1,180
Birtinya, Heidelberg, Adelaide, Nedlands, Southport, Wahroonga, Westmead, Woodville
2025-07-24
Recruiting
Young Stroke Service Deep Phenotyping: Exploring Recovery in Young Adult Survivors of Stroke
NCT07019493Stroke Patients, Stroke, Stroke; Sequelae, Young Adults
The Florey Institute of Neuroscience and Mental Health
Observational
100
Heidelberg
2025-07-19
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Westmead, Heidelberg, Melbourne
2025-07-17
Active, closed
Praxis Precision Medicines
Phase 3
160
Heidelberg
2025-07-09
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Camperdown, Darlinghurst, Kogarah, Macquarie Park, Bedford Park, Woodville, Box Hill, Heidelberg
2025-07-02
Not yet open
Use of Water Ingestion in Small Intestine Ultrasound
NCT07079007Crohn Disease (CD), Intestine Ultrasonography
Austin Health
Observational
55
Heidelberg
2025-07
Active, closed
Arrowhead Pharmaceuticals
Phase 3
70
Camperdown, Saint Leonards, Heidelberg, Nedlands
2025-06-17
Recruiting
GlaxoSmithKline
Phase 1/2
346
Heidelberg, Melbourne
2025-06-11
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
156
South Brisbane, Heidelberg, Nedlands, Randwick
2025-06-10
Recruiting
Celgene
Phase 2
200
Newcastle, Sydney, Kent Town, Hobart, Box Hill, Heidelberg, Parkville, Nedlands
2025-06-05
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Murdoch, Concord, Heidelberg, Liverpool, Melbourne, South Brisbane, Woolloongabba
2025-05-27
Recruiting
A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
NCT06921837Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma
Bolt Biotherapeutics, Inc.
Phase 1/2
122
Darlinghurst, Westmead, Birtinya, Clayton, Heidelberg
2025-05-26
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
DrugsVinblastine·Methotrexate·Doxorubicin·Durvalumab
AstraZeneca
Phase 2
150
Chermside, Elizabeth Vale, Heidelberg, Hong Kong, Kogarah, Macquarie University, Murdoch, Port Macquarie
2025-05-15
Recruiting
AstraZeneca
Phase 3
1,220
Camperdown, Clayton, Heidelberg, Randwick, South Brisbane
2025-05-06
Recruiting
AbbVie
Phase 2
390
Sydney, South Brisbane, Woodville South, Heidelberg, Nedlands
2025-04-24
Recruiting
Eli Lilly and Company
Phase 3
700
Auchenflower, Birtinya, Heidelberg, Kurralta Park, North Tamworth, Perth, Shepparton, Traralgon
2025-03-27
Recruiting
AstraZeneca
Phase 3
840
Darlinghurst, Heidelberg, Murdoch, Westmead
2025-03-01
Recruiting
Spinal Cord Injury Neurorecovery Collaboration
NCT06871254Spinal Cord Injuries
University of Melbourne
Not applicable
24
Heidelberg
2025-03-01
Active, closed
Amgen
Phase 2
252
Clayton, Heidelberg
2025-02-26
By invitation
Longboard Pharmaceuticals
Phase 3
324
Randwick, Westmead, Brisbane, Heidelberg, Parkville
2025-02-12
Recruiting
BioNTech SE
Phase 3
621
Waratah, Wollongong, Cairns, Kurralta Park, Woodville, Frankston, Heidelberg, St Albans
2025-02-03
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Heidelberg, Melbourne, Nedlands
2025-01-30
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Camperdown, Kingswood, Waratah, Southport, Tugun, Heidelberg, North Melbourne, Murdoch
2025-01-28
Active, closed
AbbVie
Phase 1
4
Sydney, Southport, Heidelberg, Perth
2025-01-27
Recruiting
Ascentage Pharma Group Inc.
Phase 3
490
Blacktown, Cooloongup, Epping, Heidelberg, Kingswood, Liverpool, Melbourne, Perth
2025-01-22
Recruiting
Implementing Surgery School Prehabilitation Using Telehealth
NCT06631872Adults Waiting to Undergo Lung Cancer or Major Abdominal, Open or Video Assisted Cancer Surgery
University of Melbourne
Not applicable
515
New Lambton Heights, Waratah, Southport, Woolloongabba, Burnie, Launceston, Heidelberg, Melbourne
2025-01-22
Recruiting
Incyte Corporation
Phase 3
240
Sydney, Adelaide, Heidelberg
2025-01-21
Active, closed
Stemline Therapeutics, Inc.
Phase 2
85
Concord, Douglas, Adelaide, Box Hill, Clayton, Fitzroy, Heidelberg, Perth
2025-01-14
Recruiting
BeOne Medicines
Phase 1
695
Blacktown, Woolloongabba, Clayton, Heidelberg, Nedlands
2025-01-10
Recruiting
Praxis Precision Medicines
Phase 2
50
Heidelberg, Melbourne
2025-01-10
Recruiting
BlossomHill Therapeutics
Phase 1/2
675
Heidelberg, Melbourne
2025-01-09
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
190
Westmead, Wollongong, Heidelberg
2024-12-30
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Concord, Heidelberg, South Woodville, St Albans
2024-12-12
Active, closed
Vicore Pharma AB
Phase 2
378
Footscray, Adelaide, Brisbane, Concord, Darlinghurst, Douglas, Heidelberg, Sydney
2024-12-09
Recruiting
BMB-101 in Absence Epilepsy and DEE
NCT06401538Absence Epilepsy, Jeavons Syndrome, Dravet Syndrome, Lennox Gastaut Syndrome
DrugBMB-101
Bright Minds Biosciences Pty Ltd
Phase 2
20
Randwick, Herston, Fitzroy, Heidelberg, Melbourne
2024-12-05
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Heidelberg, Kogarah, Macquarie University, Nedlands
2024-11-27
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Concord, Kingswood, Liverpool, Westmead, Clayton, Heidelberg, Parkville, Perth
2024-11-12
Active, closed
Longboard Pharmaceuticals
Phase 3
367
Randwick, Westmead, Brisbane, Heidelberg, Melbourne, Parkville
2024-11-11
Recruiting
Pathios Therapeutics Pty Ltd
Phase 1/2
30
Blacktown, Randwick, Adelaide, Heidelberg, Nedlands
2024-11-04
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Concord, Kingswood, Liverpool, Westmead, Birtinya, Clayton, Heidelberg, Parkville
2024-10-14
Active, closed
AstraZeneca
Phase 3
768
Fitzroy, Heidelberg, Kogarah, Liverpool, Nedlands, St Leonards, Westmead, Woolloongabba
2024-10-04
Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
NCT06561048Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
DrugsBelinostat·Pralatrexate·Soquelitinib
Corvus Pharmaceuticals, Inc.
Phase 3
150
Darlinghurst, Kogarah, South Brisbane, Adelaide, Bedford Park, Hobart, Box Hill, Heidelberg
2024-10-02
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Garran, Camperdown, Westmead, Chermside, Adelaide, Heidelberg, Melbourne, Murdoch
2024-09-26
Active, closed
Longboard Pharmaceuticals
Phase 3
108
Randwick, Westmead, Brisbane, Heidelberg, Melbourne, Parkville
2024-09-25
Active, closed
Hoffmann-La Roche
Phase 1
34
Darlinghurst, Heidelberg
2024-09-16
Active, closed
Janssen Research & Development, LLC
Phase 2
11
Camperdown, Heidelberg, Melbourne
2024-09-16
Recruiting
Bayer
Phase 3
444
Blacktown, Concord, Waratah, Buderim, Toowoomba, Heidelberg
2024-08-28
Recruiting
Silexan in the Treatment Of Posttraumatic Stress Disorder Trial
NCT06412757Post Traumatic Stress Disorder
Deakin University
Phase 3
278
Carlton, Geelong, Heidelberg, Melbourne
2024-08-26
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
DrugVedolizumab
Alimentiv Inc.
Phase 4
304
Concord, South Brisbane, Adelaide, Woodville, Epping, Heidelberg, Melbourne, Murdoch
2024-08-07
Recruiting
AstraZeneca
Phase 3
1,018
Clayton, Darlinghurst, Garran, Heidelberg, Macquarie University, Nedlands
2024-08-07
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-07-30
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
116
Wollongong, Heidelberg, Melbourne
2024-07-29
Recruiting
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
520
Sydney, Wollongong, Melbourne, Perth, Brisbane, East Maitland, Heidelberg, Malvern
2024-07-26
Recruiting
Amgen
Phase 3
450
Camperdown, Toowoomba, Woolloongabba, Bedford Park, Woodville South, Heidelberg
2024-07-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Westmead, Adelaide, Clayton, Heidelberg, Perth
2024-07-16
Recruiting
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
NCT07491172Cardiovascular, Metabolic Disease, Dyslipidemias, Lipid Disorder
CRISPR Therapeutics AG
Phase 1
90
Adelaide, Brisbane, Camperdown, Heidelberg, Melbourne
2024-06-21
Active, closed
Celgene
Phase 3
850
Gosford, Sydney, Westmead, Tiwi, Birtinya, Southport, Frankston, Heidelberg
2024-06-19
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Fitzroy, Heidelberg, Melbourne
2024-06-19
Recruiting
Allogene Therapeutics
Phase 2
250
Waratah, Auchenflower, Hobart, Clayton, Fitzroy, Heidelberg, Nedlands
2024-06-18
Recruiting
Mozart Therapeutics Australia Pty Ltd
Phase 1
96
Heidelberg, Melbourne, Fitzroy
2024-06-13
Recruiting
Immunocore Ltd
Phase 3
680
Waratah, Greenslopes, Nedlands, Heidelberg, North Melbourne, Wollstonecraft, Woolloongabba
2024-06-05
Active, closed
Amgen
Phase 1
120
Camperdown, St Leonards, Woodville South, Heidelberg, Melbourne, St Albans
2024-05-29
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,800
Adelaide, Fitzroy, Greenslopes, Heidelberg, Herston, Murdoch, Perth, South Brisbane
2024-05-24
Active, closed
Alnylam Pharmaceuticals
Phase 2
210
Adelaide, Brisbane, Heidelberg, Nedlands, Parkville
2024-05-17
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-05-13
Active, closed
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
NCT06267391Type 2 Diabetes Mellitus, Type2diabetes, Diabetes Mellitus, Type 2, Diabetes
Endogenex, Inc.
Not applicable
350
Camperdown, Double Bay, Saint Leonards, Box Hill, Fitzroy, Heidelberg, Melbourne
2024-05-01
Active, closed
Ferronova Pty Ltd
Not applicable
60
Adelaide, Bedford Park, Heidelberg, Melbourne
2024-03-21
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,350
Brisbane, Herston, South Brisbane, Adelaide, Bedford Park, Clayton, Heidelberg, Perth
2024-03-13
Recruiting
A Study of MGC026 in Participants With Advanced Solid Tumors
NCT06242470Advanced Solid Tumor, Advanced Cancer, Metastatic Cancer, Squamous Cell Carcinoma of Head and Neck
DrugKeytruda
MacroGenics
Phase 1
394
Auchenflower, Kurralta Park, Heidelberg
2024-03-06
Active, closed
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
NCT06238479Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company
Phase 1
490
Heidelberg, Kurralta Park
2024-03-05
Active, closed
Regeneron Pharmaceuticals
Phase 3
216
Woolloongabba, Heidelberg
2024-02-15
Active, closed
Boehringer Ingelheim
Phase 3
428
Randwick, St Leonards, Woolloongabba, Heidelberg, Subiaco
2024-02-09
Active, closed
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
NCT06157541Glioblastoma Multiforme, Astrocytoma, Grade IV
DrugsKeytruda·Pembrolizumab
Queensland Institute of Medical Research
Phase 1/2
58
Bowen Hills, Herston, Woolloongabba, Heidelberg
2024-02-08
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Garran, Heidelberg, Melbourne, Murdoch
2023-12-20
Active, closed
AstraZeneca
Phase 2
108
Heidelberg, Kogarah, Nedlands, Sydney
2023-12-13
Active, closed
Janssen Research & Development, LLC
Phase 1
70
Heidelberg, Melbourne, Nedlands, Randwick
2023-12-06
Recruiting
Montefiore Medical Center
Observational
5,000
Heidelberg
2023-12-05
Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT06120283Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer
DrugsBGB-43395·Elacestrant·Letrozole·Fulvestrant
BeOne Medicines
Phase 1
433
Blacktown, Bowral, Concord, North Ryde, Douglas, Adelaide, Heidelberg, Melbourne
2023-12-01
Recruiting
AstraZeneca
Phase 3
625
Camperdown, Darlinghurst, Heidelberg, Melbourne, Nedlands, Waratah
2023-11-23
Active, closed
Akero Therapeutics, Inc
Phase 3
700
Broadmeadow, Westmead, Adelaide, Clayton, Epping, Heidelberg, Melbourne, Murdoch
2023-11-10
Recruiting
AbbVie
Phase 1
325
Camperdown, Heidelberg
2023-11-09
Active, closed
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
NCT05784441Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLC
Phase 1
21
Camperdown, Clayton, Heidelberg, Herston, Westmead
2023-11-06
Recruiting
United Therapeutics
Phase 3
698
Camperdown, Kogarah, Brisbane, Chermside, Box Hill, Clayton, Heidelberg, Midland
2023-10-30
Recruiting
Biogen
Observational
908
Heidelberg
2023-10-27
Active, closed
AstraZeneca
Phase 3
895
Clayton, Fitzroy, Heidelberg, South Brisbane, Sydney
2023-10-24
Active, closed
Bristol-Myers Squibb
Phase 3
402
Blacktown, Camperdown, Coffs Harbour, Gold Coast, Clayton, Heidelberg
2023-10-24
Recruiting
University Health Network, Toronto
Phase 2
80
Heidelberg
2023-09-29
Recruiting
Biotest
Phase 3
590
Woolloongabba, Clayton, Footscray, Heidelberg, Saint Albans, Nedlands
2023-09-09
Active, closed
Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.
NCT05788081Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV
DrugsGolcadomide·Opdivo·Rituximab·Nivolumab
Olivia Newton-John Cancer Research Institute
Phase 2
40
Ballarat, Box Hill, Geelong, Heidelberg, Perth
2023-08-31
Recruiting
GlaxoSmithKline
Phase 3
892
Newcastle, St Leonards, Woolangabba, Heidelberg, Melbourne
2023-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
390
Brisbane, Heidelberg
2023-06-23
Active, closed
ArriVent BioPharma, Inc.
Phase 3
398
Heidelberg, Blacktown, St Leonards, Woolloongabba
2023-06-01
Active, closed
Grey Wolf Therapeutics
Phase 1/2
300
Bedford Park, Blacktown, Darlinghurst, Heidelberg, Melbourne, South Brisbane, Wollongong
2023-05-21
Recruiting
Genentech, Inc.
Phase 1
210
Darlinghurst, New South Wales, Clayton, Heidelberg
2023-05-02
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Randwick, Camperdown, Fitzroy, Heidelberg, Kogarah, Melbourne, Parkville, South Brisbane
2023-04-25
By invitation
Sanofi
Phase 2
70
Blacktown, Saint Leonards, Wollongong, Heidelberg, Melbourne, Richmond
2023-04-05
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Heidelberg, Macquarie University, Nedlands, South Brisbane
2023-03-23
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Adelaide, Box Hill, Campbelltown, Camperdown, Clayton, Fitzroy, Heidelberg, Herston
2023-02-15
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Kogarah, South Brisbane, Melbourne, Heidelberg, Parkville
2023-02-14
Active, closed
Genmab
Phase 3
900
Liverpool, Adelaide, Clayton, Heidelberg, Melbourne, Nedlands, Perth
2023-02-08
Recruiting
Supernus Pharmaceuticals, Inc.
Phase 2
60
Randwick, Sydney, Brisbane, Box Hill, Heidelberg, Melbourne, Parkville
2023-02-07
Recruiting
Jazz Pharmaceuticals
Phase 3
510
Randwick, Sydney, Herston, Hobart, Heidelberg, Nedlands
2023-01-23
Recruiting
Alleviant ALLAY-HF Study
NCT05685303Heart Failure
Alleviant Medical, Inc.
Not applicable
700
Clayton, Heidelberg
2023-01-10
Active, closed
AbbVie
Phase 1
288
Camperdown, Darlinghurst, Heidelberg, Melbourne
2022-12-05
Recruiting
Monash University
Phase 2/3
300
Garran, Concord, St Leonards, Clayton, Heidelberg, Melbourne, St Albans
2022-11-30
Active, closed
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
NCT05544552Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor, Urothelial Carcinoma
DrugTYRA-300
Tyra Biosciences, Inc
Phase 1/2
310
Macquarie Park, Southport, Woolloongabba, Heidelberg, Melbourne, Nedlands
2022-11-22
Recruiting
Canadian Cancer Trials Group
Phase 2
84
Concord, Nowra, Wollongong, Adelaide, Heidelberg, Perth
2022-11-01
Active, closed
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
NCT05483868Non-muscle-invasive Bladder Cancer, NMIBC, Non-Muscle Invasive Bladder Carcinoma, Non-Muscle Invasive Bladder Neoplasms
DrugBel-sar
Aura Biosciences
Phase 1
55
Westmead, Heidelberg, Langwarrin, Parkville, Nedlands
2022-09-26
Active, closed
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
DrugElironrasib
Revolution Medicines, Inc.
Phase 1
222
Sydney, Frankston, Heidelberg, Warrnambool
2022-09-19
Active, closed
Exelixis
Phase 3
901
Albury, Bankstown, Bedford Park, Heidelberg, Melbourne, Port Macquarie, Woodville South
2022-09-07
Active, closed
AbbVie
Observational
785
Blacktown, Kingswood, North Mackay, Heidelberg, Parkville
2022-08-15
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
Garran, Tweed Heads, Kurralta Park, Heidelberg, Murdoch
2022-08-08
Active, closed
Pfizer
Phase 2
108
Heidelberg, Melbourne, Parkville
2022-07-11
Active, closed
ArriVent BioPharma, Inc.
Phase 1
160
Blacktown, St Leonards, Heidelberg
2022-06-30
Active, closed
AstraZeneca
Phase 1/2
174
Camperdown, Darlinghurst, East Melbourne, Heidelberg, Melbourne, St Leonards
2022-06-02
Active, closed
AbbVie
Phase 1
34
Liverpool, Fitzroy, Fitzroy Melbourne, Heidelberg, Richmond
2022-05-17
Active, closed
Pierre Fabre Medicament
Phase 3
815
Sydney, Wollstonecraft, Woolloongabba, North Adelaide, Box Hill, Heidelberg, Prahran, Nedlands
2022-05-02
Recruiting
SK Life Science, Inc.
Phase 3
252
Heidelberg, Melbourne, Nedlands, South Brisbane
2022-04-28
Recruiting
Aulos Bioscience, Inc.
Phase 1/2
159
Miranda, Bedford Park, Clayton, Frankston, Heidelberg, Melbourne, Saint Albans
2022-04-04
Recruiting
AbbVie
Phase 3
768
Port Macquarie, Westmead, Geelong, Heidelberg
2022-03-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Blacktown, Macquarie University, North Tamworth, Brisbane, Elizabeth Vale, Heidelberg, Murdoch
2022-03-15
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Camperdown, Macquarie University, Westmead, Adelaide, Bedford Park, Box Hill, Heidelberg, Subiaco
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Heidelberg, Mount Waverley, Camperdown, Woodville South
2022-03-04
Active, closed
AstraZeneca
Phase 3
1,051
Box Hill, East Melbourne, Elizabeth Vale, Gosford, Heidelberg, Kogarah, South Brisbane, St Albans
2022-02-07
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Adelaide, Bedford Park, Campbelltown, Chermside, Clayton, Halls Creek, Heidelberg, Melbourne
2022-02-07
Recruiting
Concord Repatriation General Hospital
Not applicable
476
Camperdown, Concord, Gosford, Randwick, Westmead, Brisbane, Fitzroy, Heidelberg
2022-01
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Bedford Park, Heidelberg, Liverpool, Murdoch
2021-12-02
Active, closed
Boehringer Ingelheim
Phase 1
151
Albury, Darlinghurst, Douglas, Heidelberg
2021-10-18
Active, closed
AbbVie
Phase 1
520
South Brisbane, Heidelberg
2021-10-13
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
DrugTacabrutideg
BeOne Medicines
Phase 1/2
689
Concord, Waratah, Woolloongabba, Fitzroy, Heidelberg, Melbourne, Nedlands, West Perth
2021-09-13
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Camperdown, Fitzroy, Heidelberg, Herston, Melbourne, Murdoch, Waratah, Westmead
2021-08-19
Active, closed
Inventiva Pharma
Phase 3
1,000
Concord, Liverpool, Penrith, Greenslopes, Herston, Box Hill, Clayton, Heidelberg
2021-08-19
Active, closed
The Cryopreserved vs. Liquid Platelets Trial
NCT03991481Surgical Blood Loss, Hemorrhage
Australian and New Zealand Intensive Care Research Centre
Phase 3
388
Sydney, Brisbane, Douglas, Southport, Fitzroy, Heidelberg
2021-08-17
Active, closed
Olivia Newton-John Cancer Research Institute
Phase 2
15
Ballarat, Box Hill, Heidelberg
2021-08-17
Active, closed
Akeso
Phase 3
296
Camperdown, Darlinghurst, St Leonards, Heidelberg, Nedlands
2021-08-16
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Waratah, Wollstonecraft, Southport, Heidelberg, Perth
2021-08-04
Active, closed
JOTEC GmbH
Observational
114
Heidelberg
2021-08-01
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
European Foundation for Study of Chronic Liver Failure
Observational
3,000
Heidelberg, Nedlands, Sydney
2021-07-08
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Bedford Park, Clayton, Garran, Heidelberg, Melbourne, Waratah
2021-06-24
Active, closed
AstraZeneca
Phase 3
506
Adelaide, Auchenflower, Clayton, Heidelberg, St Leonards, Subiaco
2021-06-22
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT04771130Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
DrugsPosaconazole·Sonrotoclax·Azacitidine
BeOne Medicines
Phase 1/2
260
Concord, Kogarah, Orange, Southport, Clayton, Fitzroy, Heidelberg, Melbourne
2021-05-24
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Blacktown, Wollongong, East Melbourne, Heidelberg, Nedlands, West Perth
2021-03-22
Recruiting
AstraZeneca
Phase 1
304
Adelaide, Heidelberg, Nedlands
2021-03-09
Active, closed
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
NCT04594642B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma
DrugSurovatamig
AstraZeneca
Phase 1
226
Heidelberg, Hobart, Melbourne
2021-03-02
Active, closed
AbbVie
Phase 1
81
Wollongong, Heidelberg
2021-02-23
Active, closed
Amgen
Phase 1/2
181
Randwick, Westmead, South Brisbane, Adelaide, Clayton, Heidelberg, Melbourne, Nedlands
2021-01-04
Active, closed
Pfizer
Phase 3
841
Camperdown, Liverpool, St Leonards, Herston, Woolloongabba, Adelaide, Clayton, Heidelberg
2020-12-21
Active, closed
Daiichi Sankyo
Phase 3
605
Bedford Park, Blacktown, Heidelberg, North Ryde, Sydney, Wollongong
2020-12-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Campbelltown, Kingswood, Waratah, Southport, Frankston, Heidelberg, St Albans
2020-12-08
Active, closed
Daiichi Sankyo
Phase 3
1,600
Adelaide, Camperdown, Clayton, Heidelberg, Melbourne, Nedlands, Saint Leonards, Subiaco
2020-12-04
Active, closed
Hoffmann-La Roche
Phase 3
864
Heidelberg
2020-11-26
Active, closed
AstraZeneca
Phase 1/2
702
Heidelberg, Melbourne
2020-11-12
Active, closed
Genmab
Phase 1/2
543
Heidelberg, Nedlands
2020-11-03
Active, closed
Hoffmann-La Roche
Phase 3
985
Camperdown, Liverpool, New Lambton, Woolloongabba, Box Hill, Heidelberg, Parkville
2020-10-26
Active, closed
Nyxoah S.A.
Not applicable
115
Wollongong, Heidelberg, Nedlands
2020-10-14
Active, closed
Acerta Pharma BV
Phase 3
611
Adelaide, Camperdown, Darlinghurst, Heidelberg, Hobart, Kogarah, Nedlands, Westmead
2020-10-08
Active, closed
AstraZeneca
Phase 3
370
Camperdown, Elizabeth Vale, Heidelberg, Melbourne
2020-10-02
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Bedford Park, Heidelberg, Malvern, Murdoch, Nedlands, Westmead, Wollongong, Woolloongabba
2020-09-30
Active, closed
AbbVie
Phase 3
531
Blacktown, Kogarah, Port Macquarie, Southport, Adelaide, Fitzroy Melbourne, Heidelberg
2020-09-10
Active, closed
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
NCT04482309Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
477
Auchenflower, Blacktown, Camperdown, Heidelberg, Melbourne, Nedlands
2020-08-18
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
NCT04429542Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Anal Canal, Colorectal Cancer, Squamous Cell Carcinoma of the Lung
DrugPembrolizumab
Bicara Therapeutics
Phase 1
473
Camperdown, Waratah, Heidelberg, Melbourne
2020-06-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Liverpool, St Leonards, Clayton, Heidelberg, Nedlands
2020-05-19
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Box Hill, Douglas, Heidelberg, Macquarie Park, South Australia, South Brisbane
2020-03-30
Recruiting
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
NCT04310930Pulmonary Disease Due to Mycobacteria (Diagnosis)
DrugsImipenem·Co-trimoxazole·Rifabutin·Tigecycline
The University of Queensland
Phase 2/3
300
Kogarah, South Brisbane, Woolloongabba, Heidelberg, Parkville, Perth, Adelaide, Birtinya
2020-03-02
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
East Albury, Tweed Heads, East Melbourne, Frankston, Geelong, Heidelberg, Perth
2019-11-13
Active, closed
Bristol-Myers Squibb
Phase 3
461
Sydney, Heidelberg, Melbourne, North Ballarat
2019-11-05
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
North Sydney, Westmead, Heidelberg, Melbourne, Parkville, Nedlands
2019-10-02
Active, closed
Applied Therapeutics, Inc.
Phase 3
675
Chermside, Milton, Taringa, Hobart, Geelong, Heidelberg, Melbourne
2019-09-20
Active, closed
MedImmune LLC
Phase 1/2
61
Clayton, Heidelberg, Melbourne
2019-09-13
Active, closed
Pfizer
Phase 3
896
Liverpool, Birtinya, Bowen Hills, Buderim, Mackay, Maroochydore, North Mackey, Heidelberg
2019-09-05
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Camperdown, Heidelberg, Parkville
2019-08-12
Active, closed
Bristol-Myers Squibb
Phase 3
839
Westmead, Woolloongabba, Elizabeth Vale, Clayton, Heidelberg
2019-08-05
Recruiting
Global Coalition for Adaptive Research
Phase 2/3
2,250
St Leonards, Waratah, Herston, Bedford Park, Heidelberg, Melbourne
2019-07-30
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Blacktown, Camperdown, Heidelberg, Kogarah, North Melbourne, Perth, Wollongong
2019-07-09
Active, closed
AstraZeneca
Phase 3
587
Camperdown, Chermside, Elizabeth Vale, Heidelberg, Kogarah, Melbourne
2019-07-02
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Box Hill, Darlinghurst, Heidelberg, Malvern, Parkville, St Leonards, Wahroonga, Westmead
2019-06-11
Recruiting
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
NCT05651347Fetal Growth Retardation, Stillbirth and Fetal Death, Pregnancy Preterm
DrugMelatonin
Monash University
Phase 3
336
Camperdown, Newcastle, South Brisbane, Southport, North Adelaide, Clayton, Heidelberg, Parkville
2019-05-29
Recruiting
HighLife SAS
Not applicable
120
Darlinghurst, Newcastle, Sydney, Auchenflower, Adelaide, Brisbane, Heidelberg, Melbourne
2019-05-28
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
DrugsZanzalintinib·Avelumab·Tecentriq·Atezolizumab
Exelixis
Phase 1
325
Darlinghurst, Liverpool, South Brisbane, Kurralta Park, Heidelberg
2019-03-20
Active, closed
Acerta Pharma BV
Phase 3
984
Adelaide, Darlinghurst, Heidelberg, Kogarah, Melbourne, Nedlands, Waratah, Woolloongabba
2019-02-25
Recruiting
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
NCT05685745Infant, Extremely Premature, Obstetric Labor, Premature, Premature Birth, Intensive Care, Neonatal
The University of Texas Health Science Center, Houston
Observational
5,000
South Brisbane, Heidelberg, Parkville, Perth
2019-01-01
Active, closed
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
NCT03611868Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma, P53 Mutation
DrugPembrolizumab
Ascentage Pharma Group Inc.
Phase 1/2
230
Brisbane, South Brisbane, Bedford Park, Heidelberg
2018-08-29
Active, closed
Bristol-Myers Squibb
Phase 3
545
Blacktown, Camperdown, Concord, Herston, Adelaide, Heidelberg, Nedlands
2018-04-18
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Adelaide, Clayton, Concord, Heidelberg, Nedlands, North Terrace, Parkville, Penrith
2018-04-13
Active, closed
University of Melbourne
Phase 3
760
Heidelberg, Parkville
2018-03-06
Active, closed
Dr. Eliza Hawkes
Phase 1
39
Ballarat, Box Hill, Clayton, Heidelberg, Melbourne
2017-09-07
Active, closed
Acerta Pharma BV
Phase 3
635
Bedford Park, Concord, Frankston, Gosford, Heidelberg, Herston, Kogarah, Murdoch
2017-04-05
Active, closed
AbbVie
Phase 1
163
Frankston, Heidelberg
2017-02-22
Active, closed
ITM Solucin GmbH
Phase 3
324
Saint Leonards, Heidelberg, Melbourne, Murdoch
2017-02-02
Active, closed
Eisai Inc.
Phase 3
1,069
Box Hill, Heidelberg, Hobart, Macquarie Park, South Brisbane, St Albans
2016-10-13
Active, closed
Janssen Research & Development, LLC
Phase 1
751
Camperdown, Heidelberg, Kogarah, Murdoch, Woolloongabba
2016-05-24
Active, closed
Eli Lilly and Company
Phase 2
309
Waratah, Adelaide, Heidelberg
2016-05-19
Active, closed
Hoffmann-La Roche
Phase 2
534
Liverpool, Newcastle, Bedford Park, Heidelberg
2015-11-19
Active, closed
AstraZeneca
Phase 3
682
Bedford Park, Camperdown, Darlinghurst, Heidelberg, Kogarah, Kurralta Park, Woolloongabba
2015-10-21
Active, closed
Novartis Pharmaceuticals
Phase 1
57
Heidelberg
2015-05-27
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Adelaide, Coburg, Concord, Heidelberg, Melbourne, Perth, Prahran, Wahroonga
2013-09-09
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Heidelberg, Parkville, Randwick
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Heidelberg, Parkville, Randwick
2013-08-26
Active, closed
MedImmune LLC
Phase 2
571
Adelaide, Auchenflower, Box Hill, Chermside, East Bentleigh, Gosford, Heidelberg, Nedlands
2013-05-17
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Westmead, Cairns, Herston, Woolloongabba, Adelaide, Heidelberg, Parkville, Murdoch
2013-03-18
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
St Leonards, Sydney, Brisbane, Parkville, Bedford Park, Heidelberg, Hobart, Melbourne
2007-12
Rows per page Showing 1–274 of 274
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-australia/city/heidelberg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,378 studies in total at the last sync on 14 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 274 of those studies with a site in Heidelberg.

How many clinical trials are recruiting in Heidelberg?

140 of the 274 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:19 UTC sync. A further 9 have not yet opened recruitment, 121 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Heidelberg), 274 studies
PhaseStudiesRecruitingShare
Phase 31306147.4%
Phase 2412015%
Phase 1371613.5%
Phase 1/2311911.3%
Observational1284.4%
Not applicable1174%
Phase 2/31083.6%
Early Phase 1100.4%
Phase 4110.4%

Most active sponsors

Lead sponsors with the most studies (Heidelberg)
Lead sponsorStudiesRecruiting
AstraZeneca2713
Janssen Research & Development, LLC165
Hoffmann-La Roche137
AbbVie124
Bristol-Myers Squibb94
Boehringer Ingelheim84
BeOne Medicines77
Olivia Newton-John Cancer Research Institute60
Eli Lilly and Company53
Merck Sharp & Dohme LLC50
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.